Schedule 13G ownership disclosure
QUINCE THERAPEUTICS INC
Security class unavailable · CUSIP: 22053A107
Event date: 2022-06-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 0
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001422849-22-000154
- Form type
- SC 13G
- Filer
- Capital World Investors
- CIK
- CIK 1422849
- Filed
- Jul 08, 2022
- Reporting period
- Jun 30, 2022
- Description
- Schedule 13G beneficial ownership